Company / Working Capital per Share
ENDRA Life Sciences Inc. Working Capital per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.86
FY2020
5-year range
$0.60 / $6.96
FY2017-FY2020
Trend
+42.7%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share returned to growth in FY2020 after 2 years of decline, reaching $0.86.
Based on SEC 10-K filings.
0.86 in FY2020 with a 3-year CAGR of -50.2%.
Declined from $1.52 to $0.86 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -50.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, working capital per share increased 42.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0.86 | +42.7% |
| FY2019 | $0.60 | -60.5% |
| FY2018 | $1.52 | -78.1% |
| FY2017 | $6.96 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026